Anticuerpos monoclonales terapéuticos - ICONO

Anticuerpos monoclonales terapéuticos
• Reichert, J. and Pavlou, A. (2004). Monoclonal
antibodies market. Nature Reviews 3.
• Reichert, J. M. et al. (2005). Monoclonal
antibody successes in the clinic. Nature
biotechnology 23 (9): 1073-1078.
• Ruiz Galán, O. et al. (2005). Plantas biofactoría.
Informe de Vigilancia Tecnológica. Genoma
España.
• Sharkey, R. M. and Goldenberg, D. M. (2006).
Targeted Therapy of Cancer: New Prospects for
Antibodies and Immunoconjugates. CA Cancer J.
Clin. 56 (4):226-43.
• Silverman, J. et al. (2005). Multivalent avimer
proteins evolved by exon shuffling of a family of
human receptor domains. Nature Biotechnology
23 (12):1556-1561.
• Van Droogenbroeck, B. et al. (2007). Aberrant
localization and underglycosylation of highly
accumulating single-chain Fv-Fc antibodies in
transgenic Arabidopsis seeds. Proc. Natl. Acad.
Sci. USA. 104 (4):1430-5.
• Walsh, G.M. (2006). Targeting airway
inflammation: novel therapies for the treatment
of asthma. Curr. Med. Chem. 13 (25):3105-11.
• Wolfson, W. (2006). Ablynx Makes Nanobodies
from Llama Bodies. Chemistry & Biology
13:123-1244.
• Wu, A. M.; Senter, P. D. (2005). Arming
antibodies: prospects and challenges for
immunoconjugates. Nature Biotechnology 23
(9): 1137-1146.
• Smith, J. et al. (2005). Antibody phage display
technologies with special reference to
angiogenesis. The FASEB Journal. 19:331-341.
58